Independent editorial
White Rabbit Frontiers explores longevity, AI, regenerative medicine, the body as data, quantum sensing, and frontier science — with curiosity, rigor, and a clear eye for what's established versus what's still speculation.
Our approach
We go deep on the science that's reshaping what it means to be human — and we tell you when something is peer-reviewed consensus versus a promising early signal. No hype cycles. No undisclosed conflicts. Just careful reading of the frontier.
Findings backed by replicated research and scientific consensus.
Early-stage research with credible methodology but limited replication.
Hypotheses, preprints, and ideas worth watching — clearly labeled as such.
Featured investigations
These are placeholder titles for your review. Replace with your actual investigations before publishing.
A plain-language guide to the nine (now twelve) hallmarks framework — what it is, where it came from, and what researchers are doing about each one. Placeholder — do not publish without your own research and review.
Foundation models trained on genomic data are beginning to surface patterns that eluded decades of GWAS studies. We look at what's real, what's overstated, and what the regulatory landscape looks like. Placeholder — do not publish without your own research and review.
Partial reprogramming has reversed aging markers in animal models. The gap between mouse and human remains vast. Here's an honest accounting of where the field stands. Placeholder — do not publish without your own research and review.
White Rabbit Radar
Short dispatches on early-stage findings, preprints, and ideas that haven't yet earned the full investigation treatment. Clearly labeled as speculative or preliminary.
A handful of labs are revisiting whether quantum effects play a functional role in photosynthesis, bird navigation, and possibly enzyme catalysis. The evidence is contested. Placeholder — replace with your own sourced summary.
Wearable biosensors for lactate, cortisol, and uric acid are leaving the lab. What the data means — and what it doesn't — is still being worked out. Placeholder — replace with your own sourced summary.
Drugs that selectively clear senescent cells have shown promise in animal models for years. The first human trials are producing data. It's early. Placeholder — replace with your own sourced summary.
Two years after the protein structure database opened, researchers are beginning to quantify how structure prediction is changing early-stage drug discovery pipelines. Placeholder — replace with your own sourced summary.
Stay in the loop
Investigations, radar signals, and the occasional deep dive — delivered when there's something worth saying. No filler. Unsubscribe any time.
No spam. Unsubscribe any time.
Contact
Have a tip, a correction, or a research area you think we should be covering? We'd like to hear from you.
